86 related articles for article (PubMed ID: 9932216)
1. Should there be systematic screening of coronary heart disease in asymptomatic patients with risk factors alone? A decision analysis approach.
Junod AF
Diabetes Metab; 1998 Dec; 24(6):496-507. PubMed ID: 9932216
[TBL] [Abstract][Full Text] [Related]
2. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy.
Ess SM; Szucs TD
Ital Heart J; 2001 Mar; 2(3):181-8. PubMed ID: 11305529
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?
van Hout BA; Simoons ML
Eur Heart J; 2001 May; 22(9):751-61. PubMed ID: 11350107
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T
Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690
[TBL] [Abstract][Full Text] [Related]
5. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
6. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes.
Rutter MK; Nesto RW
Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):26-35. PubMed ID: 17179927
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive assessment of the risk of coronary heart disease.
Richie RC
J Insur Med; 2002; 34(1):31-42. PubMed ID: 15303592
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
12. [All mortality by cause of death. The challenge of coronary prevention].
Fernández-Cruz A
Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
[TBL] [Abstract][Full Text] [Related]
13. [Cost-effect clinical analysis in choice of methods of coronary heart disease diagnosis].
Kalashnikov VIu; Mitriagina SN; Syrkin AL; Poltavskaia MG
Ter Arkh; 2008; 80(4):8-11. PubMed ID: 18491572
[TBL] [Abstract][Full Text] [Related]
14. Coronary heart disease: an expensive Air Force problem.
DeHart RM
Aviat Space Environ Med; 1980 Sep; 51(9 Pt 2):1057-63. PubMed ID: 7417179
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol and coronary heart disease: screening and treatment.
Turner-Boutle M
Nurs Times; 1998 Apr 15-21; 94(15):46-7. PubMed ID: 9615661
[TBL] [Abstract][Full Text] [Related]
16. Screening guidelines for coronary heart disease in diabetes: current recommendations.
Singh S; Duggal J; Khosla N; Arora R
J Cardiometab Syndr; 2009; 4(2):107-12. PubMed ID: 19614798
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity and specificity in AIDS screening system].
Kamae I; Yamamoto K
Rinsho Byori; 1994 Jun; 42(6):580-4. PubMed ID: 8051800
[TBL] [Abstract][Full Text] [Related]
18. Detection of chronic liver disease: costs and benefits.
Quinn PG; Johnston DE
Gastroenterologist; 1997 Mar; 5(1):58-77. PubMed ID: 9074920
[TBL] [Abstract][Full Text] [Related]
19. The basics of decision analysis.
Kent DL
J Dent Educ; 1992 Dec; 56(12):791-9. PubMed ID: 1487581
[TBL] [Abstract][Full Text] [Related]
20. Screening for disease, cost-effectiveness, and guidelines.
Meyer DL
Prim Care; 1995 Dec; 22(4):591-9. PubMed ID: 8668731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
